Aimée Dallob - Concepedia

Author

Aimée Dallob

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

A Dallob, A. Dallob, A. L. DALLOB, A. L. Dallob, Aimee Dallob, Aimee L. Dallob, Aimée Dallob

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)University of Oxford Thomas Jefferson University Merck Canada Inc. (Canada)United States Military Academy

About

Aimée Dallob is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	904
2	Natural Sciences	3	3	340
3	Social Sciences	3	3	117
4	Health Sciences	1	1	32
5	Allergy	1	1	24

Aimée Dallob

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Comparative Inhibitory Activity of Rofecoxib, Meloxicam, Diclofenac, Ibuprofen, and Naproxen on COX‐2 versus COX‐1 in Healthy Volunteers Anne Van Hecken, Jules I. Schwartz, Marleen Depré, The Journal of Clinical Pharmacology	2000	355
A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors Christine Brideau, Stacia Kargman, S. Liu, Inflammation Research Therapeutic Drug MonitoringMedicinal ChemistryPharmacological StudyBiochemistryNatural Sciences	1996	281
The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia Lynn A. Drake, Maria Hordinsky, Virginia C. Fiedler, Journal of the American Academy of Dermatology Serum Androgen LevelsMedicineScalp SkinSkin PharmacologyDermatology	1999	182
Cerebrospinal Fluid Biomarkers Distinguish Postmortem-Confirmed Alzheimer's Disease from Other Dementias and Healthy Controls in the OPTIMA Cohort Jeffrey L. Seeburger, Daniel Holder, Marc Combrinck, Journal of Alzheimer s Disease	2015	97
Characterization of Etoricoxib, a Novel, Selective COX‐2 Inhibitor Aimée Dallob, Christopher J. Hawkey, Howard Greenberg, The Journal of Clinical Pharmacology	2003	91
The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness Aimée Dallob The Journal of Clinical Endocrinology & Metabolism AndrologyUrologyMedicineAlpha-reductase InhibitorAromatase	1994	89
Enhanced serotonin receptor activity after chronic treatment with imipramine or amitriptyline. Eitan Friedman, Aimée Dallob Munich Personal RePEc Archive (Ludwig Maximilian University of Munich)	1979	73
High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer’s Disease in Human Cerebrospinal Fluid Ronald C. Hendrickson, Anita Y. H. Lee, Qinghua Song, PLoS ONE Human Cerebrospinal FluidNeurochemical BiomarkersProteomic TechnologyAlzheimer's DiseaseHuman Csf	2015	71
Effects of chronic antidepressant treatment on serotonin receptor activity in mice Eitan Friedman, Thomas B. Cooper, Aimée Dallob European Journal of Pharmacology Psychoactive DrugPsychiatryAddictionMedicinePsychopharmacology	1983	52
Comparative Inhibitory Activity of Etoricoxib, Celecoxib, and Diclofenac on COX‐2 Versus COX‐1 in Healthy Subjects Jules I. Schwartz, Aimée Dallob, Patrick Larson, The Journal of Clinical Pharmacology Cox‐2 Versus Cox‐1Healthy SubjectsChemoprevention StrategyWhole BloodPharmacotherapy	2008	46

Page 1